Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses

Neuroscience

Volumn 149, Issue 1, 2007, Pages 87-98

  Szklarczyk, A ^a,b,c   Conant, K ^c   Owens, D F ^b   Ravin, R ^b   McKay, R D ^b   Gerfen, C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

neurotransmission; proteolysis; SNAP 25; strength; synapse disassembly

Indexed keywords

MATRILYSIN; PROTEIN ANTIBODY; RECOMBINANT ENZYME; SYNAPTOTAGMIN I;

ANIMAL CELL; ARTICLE; ATROPHY; CONTROLLED STUDY; NERVE CELL CULTURE; NERVE ENDING; NERVE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; SYNAPSE VESICLE;

ANIMALS; ATROPHY; CELLS, CULTURED; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 7; MICROSCOPY, IMMUNOELECTRON; NEURONS; PROTEIN TRANSPORT; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; SYNAPTIC VESICLES; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2;

EID: 34748838418     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.07.032     Document Type: Article

References (78)

1. Anthony D.C., Ferguson B., Matyzak M.K., Miller K.M., Esiri M.M., and Perry V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23 (1997) 406-415
2. Bacci A., Coco S., Pravettoni E., Schenk U., Armano S., Frassoni C., Verderio C., De Camilli P., and Matteoli M. Chronic blockade of glutamate receptors enhances presynaptic release and downregulates the interaction between synaptophysin-synaptobrevin-vesicle-associated membrane protein 2. J Neurosci 21 (2001) 6588-6596
3. Bamji S.X., Rico B., Kimes N., and Reichardt L.F. BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-beta-catenin interactions. J Cell Biol 174 (2006) 289-299
4. Bamji S.X., Shimazu K., Kimes N., Huelsken J., Birchmeier W., Lu B., and Reichardt L.F. Role of beta-catenin in synaptic vesicle localization and presynaptic assembly. Neuron 40 (2003) 719-731
5. Baranes D., Lederfein D., Huang Y.Y., Chen M., Bailey C.H., and Kandel E.R. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21 (1998) 813-825
6. Basbaum C.B., and Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 8 (1996) 731-738
7. Becher A., Drenckhahn A., Pahner I., Margittai M., Jahn R., and Ahnert-Hilger G. The synaptophysin-synaptobrevin complex: a hallmark of synaptic vesicle maturation. J Neurosci 19 (1999) 1922-1931
8. Bilousova T.V., Rusakov D.A., Ethell D.W., and Ethell I.M. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J Neurochem 97 (2006) 44-56
9. Blondel O., Collin C., McCarran W.J., Zhu S., Zamostiano R., Gozes I., Brenneman D.E., and McKay R.D. A glia-derived signal regulating neuronal differentiation. J Neurosci 20 (2000) 8012-8020
10. Chi P., Greengard P., and Ryan T.A. Synapsin dispersion and reclustering during synaptic activity. Nat Neurosci 4 (2001) 1187-1193
11. Coleman P.D., and Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24 (2003) 1023-1027
12. Conant K., McArthur J.C., Griffin D.E., Sjulson L., Wahl L.M., and Irani D.N. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46 (1999) 391-398
13. Connold A.L., Evers J.V., and Vrbova G. Effect of low calcium and protease inhibitors on synapse elimination during postnatal development in the rat soleus muscle. Brain Res 393 (1986) 99-107
14. Cossins J.A., Clements J.M., Ford J., Miller K.M., Pigott R., Vos W., Van der Valk P., and De Groot C.J. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol (Berl) 94 (1997) 590-598
15. Dityatev A., Dityateva G., and Schachner M. Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM. Neuron 26 (2000) 207-217
16. Eaton B.A., and Davis G.W. Synapse disassembly. Genes Dev 17 (2003) 2075-2082
17. Ebihara T., Kawabata I., Usui S., Sobue K., and Okabe S. Synchronized formation and remodeling of postsynaptic densities: long-term visualization of hippocampal neurons expressing postsynaptic density proteins tagged with green fluorescent protein. J Neurosci 23 (2003) 2170-2181
18. Egles C., Claudepierre T., Manglapus M.K., Champliaud M.F., Brunken W.J., and Hunter D.D. Laminins containing the beta2 chain modulate the precise organization of CNS synapses. Mol Cell Neurosci 34 (2007) 288-298
19. Everall I.P., Heaton R.K., Marcotte T.D., Ellis R.J., McCutchan J.A., Atkinson J.H., Grant I., Mallory M., and Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9 (1999) 209-217
20. Falo M.C., Fillmore H.L., Reeves T.M., and Phillips L.L. Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J Neurosci Res 84 (2006) 768-781
21. Freeman M.R. Sculpting the nervous system: glial control of neuronal development. Curr Opin Neurobiol 16 (2006) 119-125
22. Gehrmann J., Gold R., Linington C., Lannes-Vieira J., Wekerle H., and Kreutzberg G.W. Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system. Glia 7 (1993) 50-59
23. Gelman B.B., and Schuenke K. Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol 10 (2004) 98-108
24. Goda Y., and Davis G.W. Mechanisms of synapse assembly and disassembly. Neuron 40 (2003) 243-264
25. Hansen L.A., Daniel S.E., Wilcock G.K., and Love S. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry 64 (1998) 653-656
26. Jourquin J., Tremblay E., Bernard A., Charton G., Chaillan F.A., Marchetti E., Roman F.S., Soloway P.D., Dive V., Yiotakis A., Khrestchatisky M., and Rivera S. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur J Neurosci 22 (2005) 2569-2578
27. Kim H.J., Fillmore H.L., Reeves T.M., and Phillips L.L. Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis. Exp Neurol 192 (2005) 60-72
28. Lee R., Kermani P., Teng K.K., and Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 294 (2001) 1945-1948
29. Leib S.L., Leppert D., Clements J., and Tauber M.G. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immunol 68 (2000) 615-620
30. Lindberg R.L., De Groot C.J., Montagne L., Freitag P., van der Valk P., Kappos L., and Leppert D. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124 (2001) 1743-1753
31. Liu Y., Fields R.D., Festoff B.W., and Nelson P.G. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc Natl Acad Sci U S A 91 (1994) 10300-10304
32. Liu Y., Fields R.D., Fitzgerald S., Festoff B.W., and Nelson P.G. Proteolytic activity, synapse elimination, and the Hebb synapse. J Neurobiol 25 (1994) 325-335
33. Lochter A., Sternlicht M.D., Werb Z., and Bissell M.J. The significance of matrix metalloproteinases during early stages of tumor progression. Ann N Y Acad Sci 857 (1998) 180-193
34. Madani R., Hulo S., Toni N., Madani H., Steimer T., Muller D., and Vassalli J.D. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J 18 (1999) 3007-3012
35. Mallat M., Marin-Teva J.L., and Cheret C. Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 15 (2005) 101-107
36. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan J.A., Nelson J.A., Atkinson J.H., and Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42 (1997) 963-972
37. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 13 (2001) 534-540
38. McGuire J.K., Li Q., and Parks W.C. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162 (2003) 1831-1843
39. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., Wright J.W., and Harding J.W. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J Neurochem 96 (2006) 1227-1241
40. 2+-free medium is associated with depletion of synaptic vesicles and swelling of motor nerve terminals in situ. Neuroscience 78 (1997) 883-893
41. Milward E.A., Fitzsimmons C., Szklarczyk A., and Conant K. The matrix metalloproteinases and CNS plasticity: An overview. J Neuroimmunol 187 (2007) 9-19
42. Miyamoto S., Yano K., Sugimoto S., Ishii G., Hasebe T., Endoh Y., Kodama K., Goya M., Chiba T., and Ochiai A. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res 64 (2004) 665-671
43. Montecucco C., Schiavo G., and Pantano S. SNARE complexes and neuroexocytosis: how many, how close?. Trends Biochem Sci 30 (2005) 367-372
44. Mozhayeva M.G., Sara Y., Liu X., and Kavalali E.T. Development of vesicle pools during maturation of hippocampal synapses. J Neurosci 22 (2002) 654-665
45. Mundigl O., Verderio C., Krazewski K., De Camilli P., and Matteoli M. A radioimmunoassay to monitor synaptic activity in hippocampal neurons in vitro. Eur J Cell Biol 66 (1995) 246-256
46. Murthy V.N., and De Camilli P. Cell biology of the presynaptic terminal. Annu Rev Neurosci 26 (2003) 701-728
47. Murthy V.N., Schikorski T., Stevens C.F., and Zhu Y. Inactivity produces increases in neurotransmitter release and synapse size. Neuron 32 (2001) 673-682
48. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., Costa R.M., Silva A.J., Kaczmarek L., and Huntley G.W. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 26 (2006) 1923-1934
49. Nilsson L., Jonasson L., Nijm J., Hamsten A., and Eriksson P. Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin Chem 52 (2006) 1522-1527
50. O'Brien R.A., Ostberg A.J., and Vrbova G. Observations on the elimination of polyneuronal innervation in developing mammalian skeletal muscle. J Physiol 282 (1978) 571-582
51. Oray S., Majewska A., and Sur M. Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation. Neuron 44 (2004) 1021-1030
52. Poberai M., and Savay G. Time course of proteolytic enzyme alterations in the motor end-plates after stimulation. Acta Histochem 57 (1976) 44-48
53. Raber J., Mehta P.P., Kreifeldt M., Parsons L.H., Weiss F., Bloom F.E., and Wilson M.C. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. J Neurochem 68 (1997) 176-186
54. Ramsey M.M., Adams M.M., Ariwodola O.J., Sonntag W.E., and Weiner J.L. Functional characterization of des-IGF-1 action at excitatory synapses in the CA1 region of rat hippocampus. J Neurophysiol 94 (2005) 247-254
55. Reeves T.M., Prins M.L., Zhu J., Povlishock J.T., and Phillips L.L. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in the dentate gyrus. J Neurosci 23 (2003) 10182-10189
56. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
57. Schikorski T., and Stevens C.F. Quantitative ultrastructural analysis of hippocampal excitatory synapses. J Neurosci 17 (1997) 5858-5867
58. Shimohama S., Kamiya S., Taniguchi T., Akagawa K., and Kimura J. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease. Biochem Biophys Res Commun 236 (1997) 239-242
59. Steffensen S.C., Wilson M.C., and Henriksen S.J. Coloboma contiguous gene deletion encompassing Snap alters hippocampal plasticity. Synapse 22 (1996) 281-289
60. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
61. Sudhof T.C. The synaptic vesicle cycle. Annu Rev Neurosci 27 (2004) 509-547
62. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., and Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22 (2002) 920-930
63. Szklarczyk A., Oyler G., McKay R., Gerfen C., and Conant K. Cleavage of neuronal synaptosomal-associated protein of 25 kDa by exogenous matrix metalloproteinase-7. J Neurochem (2007) in press
64. Szklarczyk A., Stins M., Milward E.A., Ryu H., Fitzsimmons C., Sullivan D., and Conant K. Glial activation and matrix metalloproteinase release in cerebral malaria. J Neurovirol 13 (2007) 2-10
65. Tao-Cheng J.H. Activity-related redistribution of presynaptic proteins at the active zone. Neuroscience 141 (2006) 1217-1224
66. Tao-Cheng J.H., Vinade L., Pozzo-Miller L.D., Reese T.S., and Dosemeci A. Calcium/calmodulin-dependent protein kinase II clusters in adult rat hippocampal slices. Neuroscience 115 (2002) 435-440
67. tom Dieck S., Sanmarti-Vila L., Langnaese K., Richter K., Kindler S., Soyke A., Wex H., Smalla K.H., Kampf U., Franzer J.T., Stumm M., Garner C.C., and Gundelfinger E.D. Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J Cell Biol 142 (1998) 499-509
68. Turchan J., Anderson C., Hauser K.F., Sun Q., Zhang J., Liu Y., Wise P.M., Kruman I., Maragos W., Mattson M.P., Booze R., and Nath A. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2 (2001) 3
69. Vaillant C., Didier-Bazes M., Hutter A., Belin M.F., and Thomasset N. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum. J Neurosci 19 (1999) 4994-5004
70. VanSaun M., Herrera A.A., and Werle M.J. Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice. J Neurocytol 32 (2003) 1129-1142
71. Vicario-Abejon C., Owens D., McKay R., and Segal M. Role of neurotrophins in central synapse formation and stabilization. Nat Rev Neurosci 3 (2002) 965-974
72. Washbourne P., Thompson P.M., Carta M., Costa E.T., Mathews J.R., Lopez-Bendito G., Molnar Z., Becher M.W., Valenzuela C.F., Partridge L.D., and Wilson M.C. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci 5 (2002) 19-26
73. Wegner C., Esiri M.M., Chance S.A., Palace J., and Matthews P.M. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67 (2006) 960-967
74. Wekerle H. Planting and pruning in the brain: MHC antigens involved in synaptic plasticity?. Proc Natl Acad Sci U S A 102 (2005) 3-4
75. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., and Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21 (1998) 75-80
76. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2 (2001) 502-511
77. Zhai R., Olias G., Chung W.J., Lester R.A., tom Dieck S., Langnaese K., Kreutz M.R., Kindler S., Gundelfinger E.D., and Garner C.C. Temporal appearance of the presynaptic cytomatrix protein bassoon during synaptogenesis. Mol Cell Neurosci 15 (2000) 417-428
78. Zhang J.W., Deb S., and Gottschall P.E. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. Eur J Neurosci 10 (1998) 3358-3368